-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Adaptimmune Therapeutics PLC quarterly/annual Earnings Per Share, Basic history and growth rate from 2019 to 2023.
- Adaptimmune Therapeutics PLC Earnings Per Share, Basic for the quarter ending June 30, 2024 was 0.05 USD/shares.
- Adaptimmune Therapeutics PLC Earnings Per Share, Basic for the twelve months ending June 30, 2024 was -0.05 USD/shares, a 44.4% increase year-over-year.
- Adaptimmune Therapeutics PLC annual Earnings Per Share, Basic for 2023 was -0.09 USD/shares, a 47.1% increase from 2022.
- Adaptimmune Therapeutics PLC annual Earnings Per Share, Basic for 2022 was -0.17 USD/shares, unchanged from 2021.
- Adaptimmune Therapeutics PLC annual Earnings Per Share, Basic for 2021 was -0.17 USD/shares, a 13.3% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)